Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.61 CAD | -1.23% | -4.17% | -51.94% |
May. 14 | Transcript : Aptose Biosciences Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Aptose Biosciences Q1 Net Loss Falls, on Lower Expenses | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.94% | 19.53M | |
+33.27% | 50.85B | |
+0.98% | 42.82B | |
+49.00% | 42.03B | |
-4.22% | 29.55B | |
+10.98% | 26.11B | |
-21.63% | 19.13B | |
+8.37% | 13.05B | |
+27.18% | 12.16B | |
+23.37% | 12.08B |
- Stock Market
- Equities
- APS Stock
- News Aptose Biosciences Inc.
- RBC Capital on Aptose Biosciences' APTIVATE Trial, Cuts Target to US$23